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Autophagy is inhibited by the insulin-amino acid-mTOR signaling pathway. Two papers in this issue of Cell
Metabolism (Ebato et al., 2008; Jung et al., 2008) provide evidence that basal autophagy is necessary tomain-
tain the architecture and function of pancreatic b cells and that its induction in diabetic mice protects b cells
against damage by oxidative stress.Autophagy is an evolutionarily conserved
process in eukaryotes that not only de-
grades long-lived proteins to produce the
amino acids required for ATP synthesis
when nutrients are scarce (for instance,
during starvation or immediately after birth),
but also eliminates functionally redundant
or damaged intracellular structures such
as peroxisomes, mitochondria, and the
endoplasmic reticulum. Ebato et al. (2008)
and Jung et al. (2008) now demonstrate
the importance of autophagy in the preser-
vation of pancreatic b cell function.
During autophagy, part of the cytoplasm
is surrounded by a double membrane of
a still unknown origin to form an autopha-
gosome, which acquires hydrolytic en-
zymes by fusing with lysosomes or endo-
cytic compartments. The sequestered
material is degraded in the autophagoly-
sosome formed in this way. The rate-limit-
ing step in the autophagic process is auto-
phagosome formation, which involves
about 20 Atg (autophagy-related) proteins.
One of these proteins, Atg8 (LC3-I), can be
lipidated with phosphatidylethanolamine
(LC3-II), and used as an autophagosome
marker (Mizushima and Klionsky, 2007).
Autophagy is inhibited by the insulin-
amino acid-mTOR signaling pathway and
can be activated by amino acid depletion
or the administration of rapamycin. Insulin
inhibits autophagy in two ways: first by ac-
tivating mTOR in synergy with amino acids
(Codogno and Meijer, 2005), which results
in the phosphorylation and inhibition of
the protein kinase Atg1 (in yeast; ULK1 in
mammals) (Figure 1); and second by pro-
tein kinase B-mediated phosphorylation
and inhibition of the transcription factor
FoxO3,which is responsible for the expres-
sion of Atg genes (Mammucari et al., 2007).
The importance of autophagy as an
essential house-keeping function, evenunder basal (i.e., fed) conditions, is high-
lighted by the observation that tissue-
specific deletions of Atg genes result in
tissue-specific disorders, and we now
know that autophagy provides protection
against various adverse situations, in-
cluding cancer, neurodegeneration, in-
vading pathogens, and aging (Mizushima
and Klionsky, 2007; Cuervo et al., 2005).
So far, little information has been avail-
able about autophagy in insulin-resistant
states. The existing literature suggested
(Codogno and Meijer, 2005; Meijer and
Codogno, 2007) that in insulin-sensitive
cells, including b cells, autophagy might
be increased—not only because insulin in-
hibits autophagy but also because insulin
resistance develops in response to over-
feeding, which is one of the major causes
of insulin resistance, as a result of free fatty
acid-induced oxidative stress. Reactive
oxygen species (ROS) are known to be
required to trigger autophagy (Meijer and
Codogno, 2007; Scherz-Shouval et al.,
2007), probably because they oxidize
a critical cysteine residue in Atg4 (Scherz-
Shouval et al., 2007) (Figure 1). It therefore
looked as though autophagy acts as a pro-
tection mechanism against oxidative dam-
age, e.g., of mitochondria, thus preventing
damage that would produce more ROS,
and thus start a vicious circle (Meijer and
Codogno, 2007). The first demonstration
that autophagy can, indeed, act as a de-
fense mechanism against the cell damage
incurred during diabetes was provided by
the observation that diabetes-induced ox-
idative stress results in ubiquitination, and
the storage of proteins in cytoplasmic
aggregates of b cells that are cleared by
autophagy (Kaniuk et al., 2007).
In this issue, two studies are described
that nicely link up with these predictions
(Ebato et al., 2008; Jung et al., 2008).Cell MetabolismBoth groups used b cell-specific Atg7
knockout mice, and report islet degenera-
tion, decreased glucose tolerance, and re-
duced insulin secretion.One indication that
autophagy was severely impaired was the
accumulation of large ubiquitin-containing
protein aggregates with overexpression of
the LC3-binding protein p62; the p62-LC3
interaction is required for polyubiquitiny-
lated protein aggregates to be delivered
to the autophagosome for degradation.
The presence of aberrant, malformed,
and functionally defective b cell mitochon-
dria, and of a distended endoplasmic
reticulum presumably contributed to the
reduced ability to produce insulin (Jung
et al., 2008). These results clearly demon-
strate the importance of basal, constitutive
autophagy in maintaining normal islet func-
tion, which is similar to the situation in other
tissues (Mizushima and Klionsky, 2007).
Ebato et al. also studied autophagy in
b cells from diabetic animals. The level of
autophagosomes, as measured by electron
microscopic analysis, was greatly increased
in both diabetic db/db mice and in non-
diabetic control mice fed a high-fat diet. It
must be stressed that the level of autopha-
gosomes alone does not provide unequivo-
cal evidence that the autophagic flux has in-
creased, because such an increase can also
occur as a result of impaired autophago-
some/lysosome fusion, or impaired function
of the lysosomal proton pump. However,
when Atg7/ mice were fed the high-fat
diet, their glucose tolerance deteriorated fur-
ther, demonstrating the importance of au-
tophagy in maintaining proper b cell function
under stressful conditions. The authors also
studied the in vitro effect on autophagy in
INS-1 b cells of long-chain free fatty acids,
which are thought to be key mediators of in-
sulin resistance in diabetes (Ebato et al.,
2008). In the presence of a cocktail of8, October 8, 2008 ª2008 Elsevier Inc. 275
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Previewslysosome inhibitors they ob-
served an increase in LC3-II af-
ter the administration of oleate
or palmitate, which suggested
a fatty acid-induced increase
in autophagic flux.
These interesting findings
strongly suggest that autoph-
agy does indeed increase in
insulin resistance, thus pro-
tecting the b cells against cell
damage. Whether this also
applies to the insulin-sensitive
peripheral tissues remains to
be seen, but it looks likely.
However, rather than conclud-
ing that autophagy is an adap-
tive response to increased in-
sulin resistance (Ebato et al.,
2008), we should consider the
possibility that insulin resis-
tance itself could be the adap-
tive response that activates
autophagy, which in turn protects against
cell death. If this is correct, it would mean
that, even though both glucose and lipid
metabolism are severely disturbed during
insulin resistance, increasing autophagy
takes priority in order to prevent the worst.
In this context, it is noteworthy that moder-
ately defective insulin signaling can actually
enhance life span (Russell and Kahn, 2007).
It is tempting tospeculate that, analogously
with the increase in life span produced by
calorie restriction (Cuervo et al., 2005),
this could perhaps be due at least in part
to enhanced autophagic removal of dam-
aged intracellular structures.
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Figure 1. Regulation of Autophagy by Insulin and Amino Acids and
the Role of Autophagy in Pancreatic b Cells
Activation of mTOR requires input from both insulin and amino acids. Activa-
tion of mTOR stimulates protein synthesis and simultaneously inhibits autoph-
agy via phosphorylation of the protein kinase Atg1. Basal autophagy is
required to maintain b cell islet architecture and function. Stimulated autoph-
agy occurs in response to insulin resistance in b cells. The mechanism by
which free fatty acids (FFAs) stimulate autophagy remains to be elucidated.
Reactive oxygen species (ROS) may be involved.Welcoming Foxa2 in the Bile Acid Entourage
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Homeostatic regulation of bile acid metabolism and biliary lipid secretion is critical to prevent enterohepatic
diseases. Kaestner and coworkers (Bochkis et al., 2008) show that loss of forkhead box transcription factor
Foxa2 in the liver leads to hepatic injury due to downregulation in the expression levels of bile acid
transporters and detoxification enzymes.
There are several reasons why bile acids
(BA) are fascinating biological molecules.
Their life is strictly connected to the fate
of cholesterol, since their synthesis repre-
sents one critical way to decrease choles-
terol overload. Their function is historically
centered to efficient handling of ingested
lipids. BA drive biliary lipid secretion and
increase the aqueous solubilization in
the gut of otherwise insoluble substances,
such as cholesterol and liposoluble vita-
mins, thus favoring lipid digestion. Also,
they are crucial metabolic players in
energy expenditure, glucose and fatty
acid metabolism (Thomas et al., 2008).
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